ReviewInternational journal of molecular sciences2026

KRAS G12C-Targeted Therapy in Non-Small Cell Lung Cancer: From Resistant Salvage to Potential First-Line Backbone.

Daniel Rosas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.